Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.56 EUR
89.24 M EUR
508.28 M EUR
74.86 M
About MYCRONIC AB
Sector
Industry
CEO
Per Anders Lindqvist
Website
Headquarters
Täby
Founded
1989
ISIN
SE0000375115
FIGI
BBG000D93RY5
Mycronic AB engages in the development, manufacture, and sale of production equipment for electronics and display manufacturing. It operates through the following segments: Pattern Generators, High Flex, High Volume, and Global Technologies. The Pattern Generators segment specializes in the development, manufacture, and marketing of mask writers and measuring machines for production of photo masks for displays. The High Flex segment offers surface mount technology (SMT) and inspection equipment. The High Volume segment includes equipment for dispensing and conformal coating of circuit boards. The Global Technologies segment refers to the production solutions with differentiation. The company was founded in 1989 and is headquartered in Taby, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MLT is 34.86 EUR — it has decreased by −0.17% in the past 24 hours. Watch MYCRONIC AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MYCRONIC AB stocks are traded under the ticker MLT.
MLT stock has risen by 1.28% compared to the previous week, the month change is a 1.81% rise, over the last year MYCRONIC AB has showed a 32.85% increase.
We've gathered analysts' opinions on MYCRONIC AB future price: according to them, MLT price has a max estimate of 42.46 EUR and a min estimate of 38.25 EUR. Watch MLT chart and read a more detailed MYCRONIC AB stock forecast: see what analysts think of MYCRONIC AB and suggest that you do with its stocks.
MLT stock is 1.20% volatile and has beta coefficient of 0.97. Track MYCRONIC AB stock price on the chart and check out the list of the most volatile stocks — is MYCRONIC AB there?
Today MYCRONIC AB has the market capitalization of 3.40 B, it has increased by 0.23% over the last week.
Yes, you can track MYCRONIC AB financials in yearly and quarterly reports right on TradingView.
MYCRONIC AB is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
MLT earnings for the last quarter are 0.40 EUR per share, whereas the estimation was 0.32 EUR resulting in a 24.56% surprise. The estimated earnings for the next quarter are 0.29 EUR per share. See more details about MYCRONIC AB earnings.
MYCRONIC AB revenue for the last quarter amounts to 156.67 M EUR, despite the estimated figure of 138.75 M EUR. In the next quarter, revenue is expected to reach 150.48 M EUR.
MLT net income for the last quarter is 39.43 M EUR, while the quarter before that showed 25.16 M EUR of net income which accounts for 56.73% change. Track more MYCRONIC AB financial stats to get the full picture.
Yes, MLT dividends are paid annually. The last dividend per share was 0.38 EUR. As of today, Dividend Yield (TTM)% is 1.12%. Tracking MYCRONIC AB dividends might help you take more informed decisions.
MYCRONIC AB dividend yield was 1.57% in 2023, and payout ratio reached 44.01%. The year before the numbers were 1.79% and 46.10% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 28, 2024, the company has 2.04 K employees. See our rating of the largest employees — is MYCRONIC AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MYCRONIC AB EBITDA is 207.81 M EUR, and current EBITDA margin is 24.75%. See more stats in MYCRONIC AB financial statements.
Like other stocks, MLT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYCRONIC AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYCRONIC AB technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYCRONIC AB stock shows the strong buy signal. See more of MYCRONIC AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.